Results 241 to 250 of about 42,548 (287)

Consideration of patient phenotypes in geographic atrophy due to age-related macular degeneration. [PDF]

BMJ Open Ophthalmol
Singh RP, Weng CY, Kitchens JW, Quilantan J, Schwartz R, Baumal CR, Goldberg RA.   +6 more
europepmc   +1 more source

Geographic Atrophy in Age-Related Macular Degeneration. [PDF]

Dtsch Arztebl Int
Liakopoulos S, von der Emde L, Biller ML, Ach T, Holz FG.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Identifying geographic atrophy

Current Opinion in Ophthalmology, 2023
Purpose of review Age-related macular degeneration (AMD) is one of the leading causes of blindness and can progress to geographic atrophy (GA) in late stages of disease. This review article highlights recent literature which assists in the accurate and timely identification of GA, and monitoring of GA progression.
Leanne, Clevenger, Aleksandra, Rachitskaya   +1 more
openaire   +2 more sources

Geographic atrophy

Acta Ophthalmologica, 2012
AbstractAbstract not ...
M. Fleckenstein, S. Schmitz-Valckenberg, J. S. Sunness, F. G. Holz   +3 more
  +4 more sources

Genetic and molecular biomarkers for geographic atrophy

Acta Ophthalmologica, 2023
AbstractGeographic atrophy (GA) is characterized by atrophy of the retina, retinal pigment epithelium and choriocapillaris, causing a gradual loss of vision over time. Treatment options to prevent initiation or progression of GA are limited; two recently FDA‐approved inhibitors of the complement system (pegcetacoplan, avacincaptad pegol) showed a ...
Bridget Riley‐Gillis, Hannah Huh, Jie Shen, Anneke I. den Hollander   +3 more
openaire   +2 more sources

Characterisation of macular neovascularisation in geographic atrophy

British Journal of Ophthalmology, 2021
AimTo characterise macular neovascularisation (MNV) developing in eyes affected by geographic atrophy (GA).MethodsIn this multicentric longitudinal study involving three retina referral centres, patients previously affected by GA who developed an active MNV were included.
Riccardo Sacconi, Maria Brambati, Alexandra Miere, Eliana Costanzo, Vittorio Capuano, Enrico Borrelli, Marco Battista, Mariacristina Parravano, Eric H Souied, Francesco Bandello, Giuseppe Querques   +10 more
openaire   +4 more sources

Geographic Chorioretinal Atrophy in Pseudoxanthoma Elasticum

American Journal of Ophthalmology, 2013
To describe a series of patients with geographic atrophy independent of choroidal neovascularization (CNV) in pseudoxanthoma elasticum and to report progression over time.Retrospective observational case series.Records of all Vanderbilt Eye Institute patients with pseudoxanthoma elasticum and at least 1 set of color fundus photographs were reviewed (41
Scott D, Schoenberger, Anita, Agarwal
openaire   +2 more sources

Therapies for Geographic Atrophy

International Ophthalmology Clinics, 2023
Suzie A, Gasparian, Henry C, Skrehot, Christina Y, Weng   +2 more
openaire   +2 more sources

Vitreoretinal Interface Changes in Geographic Atrophy

Ophthalmology, 2014
Geographic atrophy (GA) is the end-stage manifestation of atrophic age-related macular degeneration (AMD). The disease progresses slowly over time, eventually causing loss of central vision. Its cause and pathomechanism are not fully known. Previous studies have suggested that vitreoretinal traction (VRT) may contribute to the progression of ...
Abdillahi H, Enzmann V, Wittwer VV, Wolf S, Wolf-Schnurrbusch UE   +4 more
openaire   +3 more sources

Geographic Atrophy

Advances in Ophthalmology and Optometry, 2018
Ivana N. Despotovic, Daniela Ferrara
  +4 more sources